Načítá se...
Rituximab Treatment for Nephrotic Syndrome in Children
In the past 10 years, many reports have suggested that rituximab, a chimeric anti-CD20 monoclonal antibody, is effective for children with complicated, frequently relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS). However, those reports were case reports, case series, retrospective surve...
Uloženo v:
| Vydáno v: | Curr Pediatr Rep |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4338366/ https://ncbi.nlm.nih.gov/pubmed/25741456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40124-014-0065-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|